Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death ...

My doctor was of the opinion that over-medicalisation of patients was a common problem, and that a high PSA reading might ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

Alex Pattle spent the day with the UFC heavyweight champion, his father and coach Andy, and others close to the Wigan fighter ...

Red John is an established figure among the landowners and ranchers of the Brazilian Amazon. He is the one who helps clear ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...

Scientists based in Australia and China have identified a pair of pesky enzymes responsible for prolonging prostate cancer – ...